🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicole Green

Seattle Children's Hospital

ORCID: 0000-0002-0371-0986

Also affiliated with University of Washington

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study”.

Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.07.017
N/A
0DataRank · unranked
21 citations

Wen Ye, Sarah Jane Schwarzenberg, A. Jay Freeman, Joseph J. Palermo, Alexander Weymann +20 more

The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.08.002
N/A
0DataRank · unranked
30 citations

Anna Faino, Gracia Bridges, Lauren Bartlett, Jonathan D. Cogen, Nicole Green +4 more

540 Impact of elexacaftor-tezacaftor-ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function, and fat malabsorption: Report of PROMISE PEDS GI

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01463-7
N/A
0DataRank · unranked
0 citations

Peter Vu, S. Schwarzenberg, Ben Freedman, M R Narkewicz, J. Pittman +4 more

528 Alterations in the fecal microbiota of patients with advanced cystic fibrosis–associated liver disease after 6 months of elexacaftortezacaftor-ivacaftor

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01451-0
N/A
0DataRank · unranked
0 citations

Cassie F. Pope, H. Hayden, C. Miller, S. Salipante, Steven M. Rowe +6 more

Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.02.015
N/A
0DataRank · unranked
12 citations

Christopher E. Pope, Hillary S. Hayden, Carson J. Miller, Stephen J. Salipante, Steven M. Rowe +6 more

Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.01.011
N/A
0DataRank · unranked
4 citations

Margaret Rosenfeld, Christopher H. Goss, Nicole Green, Mark Derleth, S.B. Carr +3 more